Beontheball
Nina cannot answer my questions privately. If she did she would be providing me with information not in the public domain .
My opinion is there is a disconnect between Market value of the Company and that of others conducting Phase 3 trials for the same induction, FSGS.
And I’m trying to work out why and as part of that process have entered an open discussion of the information available to us at this time with others like yourself who either hold or are interested in the Company.
But you are right, not for me at this time. Too many red flags and assumptions.
Changing sentiment according but will continue to watch.
Regards
EC
Ann: CLARITY 2.0 COVID-19 Study Concludes Recruitment, page-33
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add DXB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
44.5¢ |
Change
-0.010(2.20%) |
Mkt cap ! $247.9M | |||
| Open | High | Low | Value | Volume |
| 45.0¢ | 45.8¢ | 43.8¢ | $701.3K | 1.564M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 111371 | 44.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 45.0¢ | 8072 | 1 |
View Market Depth
| Last trade - 16.10pm 11/10/2024 (20 minute delay) ? |
| DXB (ASX) Chart |